Bayesian Capital Management, LP Conmed Corp Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
A detailed history of Bayesian Capital Management, LP transactions in Conmed Corp stock. As of the latest transaction made, Bayesian Capital Management, LP holds 7,779 shares of CNMD stock, worth $346,087. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,779Holding current value
$346,087% of portfolio
0.07%Shares
13 transactions
Others Institutions Holding CNMD
# of Institutions
298Shares Held
35.8MCall Options Held
0Put Options Held
32.1K-
Black Rock Inc. New York, NY4.99MShares$222 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.55MShares$158 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.83MShares$126 Million0.7% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.74MShares$77.4 Million0.34% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.68MShares$74.6 Million0.02% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $1.36B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...